Latest news

Posts about investor

eXoZymes details biomanufacturing breakthrough: 4 grams of NCT with over 99% purity

eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 months

World Bio Markets: AI and Machine Learning - The Silver Bullet we Must Not Dodge

Dr. Paul Opgenorth

eXoZymes selected as core industry partner in $9M NSF-funded initiative to advance modular cell-free biomanufacturing

Chris Marlett, MDB Capital

Slack Capital interview: Chris Marlett, Chairman of the Board

Slack Capital interview: Damien Perriman, CCO

Michael Heltzen & Erum Azeez Khan

eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on Grow Everything podcast

Tyler Korman

Slack Capital interview: Tyler Korman, VP of Research

Transcript: eXoZymes 1st quarter 2025 and NCTx subsidiary update

Slack Capital: EXOZ investment report and CEO interview